Table 3.
N | GS ≥7 (%) | Median age (yrs.) | Median follow-up (yrs.) | Treated (%) | |
---|---|---|---|---|---|
Johns Hopkins | 1298 | 0 | 66 | 5.0 | 36 |
Sunnybrook | 993 | 13 | 68 | 6.4 | 27 |
Göteborg | 439 | NR# | 65 | 6.0 | 37 |
UCSF | 810 | 8 | 62 (mean) | 5.0 | NR |
Royal Marsden | 471 | 7 | 66 | 5.7 | 31 |
St. Vincent’s | 650 | 14 | 63 | 4.6 | 38 |
PRIAS | 2494 | 0 | 66 | 1.6 | 21 |
University of Copenhagen | 167 | 6 | 65 | 3.4 | 35* |
University of Miami | 230 | 0 | 64 | 3.7 | 14 |
NR=Not reported.
GS ≥7 not directly reported; 22% of cohort was intermediate risk or higher.
Discontinued AS; whether treatment immediately pursued is not disclosed.